Follow
Moustapha Hassan
Moustapha Hassan
Professor
Verified email at ki.se - Homepage
Title
Cited by
Cited by
Year
Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells
K Le Blanc, I Rasmusson, B Sundberg, C Götherström, M Hassan, ...
The Lancet 363 (9419), 1439-1441, 2004
36462004
Dynamics of fat cell turnover in humans
KL Spalding, E Arner, PO Westermark, S Bernard, BA Buchholz, ...
Nature 453 (7196), 783-787, 2008
29022008
Repurposed antiviral drugs for Covid-19—interim WHO solidarity trial results
WHO Solidarity Trial Consortium
New England journal of medicine 384 (6), 497-511, 2021
26122021
Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1
MG Ott, M Schmidt, K Schwarzwaelder, S Stein, U Siler, U Koehl, H Glimm, ...
Nature medicine 12 (4), 401-409, 2006
13652006
Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta
K Le Blanc, C Götherström, O Ringdén, M Hassan, R McMahon, E Horwitz, ...
Transplantation 79 (11), 1607-1614, 2005
5672005
Inhibition of proteasome deubiquitinating activity as a new cancer therapy
P D'arcy, S Brnjic, MH Olofsson, M Fryknäs, K Lindsten, M De Cesare, ...
Nature medicine 17 (12), 1636-1640, 2011
5392011
Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study
T Güngör, P Teira, M Slatter, G Stussi, P Stepensky, D Moshous, ...
The Lancet 383 (9915), 436-448, 2014
3422014
Role of polymorphic human CYP2B6 in cyclophosphamide bioactivation
HJ Xie, Ü Yasar, S Lundgren, L Griskevicius, Y Terelius, M Hassan, ...
The pharmacogenomics journal 3 (1), 53-61, 2003
2702003
Busulfan bioavailability
M Hassan, P Ljungman, P Bolme, O Ringden, Z Syruckova, A Bekassy, ...
2641994
Biodegradable polymeric vesicles containing magnetic nanoparticles, quantum dots and anticancer drugs for drug delivery and imaging
F Ye, Å Barrefelt, H Asem, M Abedi-Valugerdi, I El-Serafi, M Saghafian, ...
Biomaterials 35 (12), 3885-3894, 2014
2482014
Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysis
IH Bartelink, A Lalmohamed, EML van Reij, CC Dvorak, RM Savic, ...
The Lancet Haematology 3 (11), e526-e536, 2016
2262016
Pharmacokinetics of high-dose busulphan in relation to age and chronopharmacology
M Hassan, G Öberg, AN Bekassy, J Aschan, H Ehrsson, P Ljungman, ...
Cancer chemotherapy and pharmacology 28, 130-134, 1991
1951991
Pharmacokinetic and metabolic studies of high-dose busulphan in adults
M Hassan, G Öberg, H Ehrsson, M Ehrnebo, I Wallin, B Smedmyr, ...
European journal of clinical pharmacology 36, 525-530, 1989
1851989
Endometrial endothelial cells are derived from donor stem cells in a bone marrow transplant recipient
M Mints, M Jansson, B Sadeghi, M Westgren, M Uzunel, M Hassan, ...
Human reproduction 23 (1), 139-143, 2008
1842008
On the bioavailability of oral and subcutaneous 2-chloro-2'-deoxyadenosine in humans: alternative routes of administration.
J Liliemark, F Albertioni, M Hassan, G Juliusson
Journal of Clinical Oncology 10 (10), 1514-1518, 1992
1831992
The effect of busulphan on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite: time interval influence on therapeutic efficacy and therapy-related toxicity
M Hassan, P Ljungman, O Ringden, Z Hassan, G Öberg, C Nilsson, ...
Bone marrow transplantation 25 (9), 915-924, 2000
1752000
Improved survival after allogeneic hematopoietic stem cell transplantation in recent years. A single-center study
M Remberger, M Ackefors, S Berglund, O Blennow, G Dahllöf, A Dlugosz, ...
Biology of Blood and Marrow Transplantation 17 (11), 1688-1697, 2011
1602011
High busulfan concentrations are associated with increased transplant-related mortality in allogeneic bone marrow transplant patients
P Ljungman, M Hassan, AN Bekassy, O Ringden, G Öberg
Bone marrow transplantation 20 (11), 909-913, 1997
1551997
Influence of prophylactic anticonvulsant therapy on high-dose busulphan kinetics
M Hassan, G Öberg, M Björkholm, I Wallin, M Lindgren
Cancer chemotherapy and pharmacology 33 (3), 181-186, 1993
1531993
Personalizing busulfan-based conditioning: considerations from the american society for blood and marrow transplantation practice guidelines committee
J Palmer, JS McCune, MA Perales, D Marks, J Bubalo, M Mohty, ...
Biology of Blood and Marrow Transplantation 22 (11), 1915-1925, 2016
1432016
The system can't perform the operation now. Try again later.
Articles 1–20